Cite
HARVARD Citation
Kohli, A. et al. (n.d.). Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Lancet infectious diseases. 15 (9), pp. 1049-1054. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kohli, A. et al. (n.d.). Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Lancet infectious diseases. 15 (9), pp. 1049-1054. [Online].